Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Takeda Pharmaceutical Total Assets 2010-2023 | TAK

Takeda Pharmaceutical total assets from 2010 to 2023. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Takeda Pharmaceutical total assets for the quarter ending December 31, 2023 were $96.716B, a 0.87% increase year-over-year.
  • Takeda Pharmaceutical total assets for 2023 were $103.287B, a 11.93% decline from 2022.
  • Takeda Pharmaceutical total assets for 2022 were $117.284B, a 3.37% decline from 2021.
  • Takeda Pharmaceutical total assets for 2021 were $121.376B, a 2.9% increase from 2020.
  
Takeda Pharmaceutical Annual Total Assets
(Millions of US $)
2023 $103,287
2022 $117,284
2021 $121,376
2020 $117,954
2019 $124,851
2018 $36,958
2017 $40,509
2016 $31,740
2015 $39,095
2014 $45,691
2013 $47,863
2012 $45,428
2011 $33,571
2010 $30,358
2009 $13,338
Takeda Pharmaceutical Quarterly Total Assets
(Millions of US $)
2023-12-31 $96,716
2023-09-30 $102,616
2023-06-30 $107,987
2023-03-31 $103,287
2022-12-31 $95,883
2022-09-30 $105,040
2022-06-30 $108,304
2022-03-31 $117,284
2021-12-31 $111,747
2021-09-30 $114,299
2021-06-30 $115,181
2021-03-31 $121,376
2020-12-31 $117,947
2020-09-30 $116,699
2020-06-30 $117,309
2020-03-31 $117,954
2019-12-31 $119,890
2019-09-30 $119,785
2019-06-30 $123,309
2018-12-31 $51,328
2018-06-30 $38,268
2017-06-30 $39,113
2016-06-30 $35,498
2015-06-30 $35,431
2015-03-31 $39,095
2014-12-31 $40,950
2014-09-30 $43,889
2014-06-30 $43,486
2014-03-31 $45,691
2013-12-31 $44,258
2013-09-30 $42,957
2013-06-30 $39,730
2013-03-31 $47,863
2012-12-31 $46,540
2012-09-30 $44,223
2012-06-30 $43,349
2012-03-31 $45,428
2011-12-31 $44,136
2011-09-30 $45,141
2011-03-31 $33,571
2010-03-31 $30,358
2009-09-30 $0
2009-03-31 $28,165
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $42.314B $29.811B
Takeda Pharmaceutical Company Limited operates as a research-based pharmaceutical company, engaged in manufacturing, marketing, and importing/exporting pharmaceutical drugs. Takeda's core business comprise of ethical drugs and its portfolio includes lansoprazole for the treatment of peptic ulcers, leuprolide acetate for the treatment of prostate cancer and endometriosis, pioglitazone hydrocholoride for the treatment of diabetes, and candesartan cilexetil for the treatment of hypertension. The Company promotes enhancing R&D pipeline, while concentrating its management resources to the four core therapeutic areas: lifestyle-related diseases, oncology and urological diseases, central nervous system disease and gastroenterological diseases. It operates in two segments- Ethical drug business and Consumer healthcare business. Consumer healthcare business provides Alinamin (vitamin B1 derivative preparations, etc.), Benza (cold remedies). Takeda Pharmaceutical Company Limited is headquartered in Osaka, Japan.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $76.411B 31.00
Chugai Pharmaceutical (CHGCY) Japan $54.679B 24.44
Merck (MKGAF) Germany $20.967B 19.78
Astellas Pharma (ALPMY) Japan $18.169B 28.69
Sandoz Group AG (SDZNY) Switzerland $14.745B 0.00
Neurocrine Biosciences (NBIX) United States $14.161B 38.76
Shionogi (SGIOY) Japan $14.115B 12.66
United Therapeutics (UTHR) United States $11.642B 12.41
Catalent (CTLT) United States $10.225B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.726B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.935B 7.62
Revolution Medicines (RVMD) United States $6.854B 0.00
Ionis Pharmaceuticals (IONS) United States $6.117B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.396B 0.00
Orion OYJ (ORINY) Finland $4.940B 20.83
Madrigal Pharmaceuticals (MDGL) United States $4.892B 0.00
Alpine Immune Sciences (ALPN) United States $4.235B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.717B 0.00
Summit Therapeutics (SMMT) United States $3.082B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $3.028B 0.00
Corcept Therapeutics (CORT) United States $2.553B 23.13
PTC Therapeutics (PTCT) United States $2.532B 0.00
Indivior (INDV) United States $2.475B 11.73
Dyne Therapeutics (DYN) United States $2.248B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.075B 11.86
Recursion Pharmaceuticals (RXRX) United States $2.074B 0.00
Ardelyx (ARDX) United States $2.040B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.948B 0.00
Evotec AG (EVO) Germany $1.868B 0.00
Fusion Pharmaceuticals (FUSN) Canada $1.820B 0.00
Catalyst Pharmaceuticals (CPRX) United States $1.737B 17.95
Avadel Pharmaceuticals (AVDL) Ireland $1.705B 0.00
Taro Pharmaceutical Industries (TARO) Israel $1.596B 27.93
Soleno Therapeutics (SLNO) United States $1.508B 0.00
Xencor (XNCR) United States $1.486B 0.00
4D Molecular Therapeutics (FDMT) United States $1.350B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.271B 11.94
Pacira BioSciences (PCRX) United States $1.266B 12.60
Collegium Pharmaceutical (COLL) United States $1.227B 7.55
Enliven Therapeutics (ELVN) United States $1.065B 0.00
Cronos Group (CRON) Canada $1.024B 0.00
Ocular Therapeutix (OCUL) United States $0.955B 0.00
Cassava Sciences (SAVA) United States $0.954B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $0.950B 0.00
ARS Pharmaceuticals (SPRY) United States $0.945B 0.00
Relay Therapeutics (RLAY) United States $0.932B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.918B 0.00
USANA Health Sciences (USNA) United States $0.876B 14.19
Sage Therapeutics (SAGE) United States $0.839B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.729B 0.00
Siga Technologies (SIGA) United States $0.722B 10.68
Silence Therapeutics (SLN) United Kingdom $0.658B 0.00
Savara (SVRA) United States $0.650B 0.00
Lyell Immunopharma (LYEL) United States $0.602B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.596B 0.00
Exscientia (EXAI) United Kingdom $0.565B 0.00
OmniAb (OABI) United States $0.547B 0.00
Verve Therapeutics (VERV) United States $0.538B 0.00
Altimmune (ALT) United States $0.518B 0.00
KalVista Pharmaceuticals (KALV) United States $0.512B 0.00
ProKidney (PROK) United States $0.505B 0.00
Larimar Therapeutics (LRMR) United States $0.495B 0.00
Korro Bio (KRRO) United States $0.467B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.459B 0.00
Lexeo Therapeutics (LXEO) United States $0.421B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.407B 0.00
Tourmaline Bio (TRML) United States $0.406B 0.00
Esperion Therapeutics (ESPR) United States $0.394B 0.00
Heron Therapeutics (HRTX) United States $0.393B 0.00
Harrow (HROW) United States $0.367B 0.00
Black Diamond Therapeutics (BDTX) United States $0.366B 0.00
Nature's Sunshine Products (NATR) United States $0.359B 20.06
Organogenesis (ORGO) United States $0.329B 62.25
Enanta Pharmaceuticals (ENTA) United States $0.321B 0.00
Aquestive Therapeutics (AQST) United States $0.320B 0.00
Bioventus (BVS) United States $0.314B 0.00
Fractyl Health (GUTS) United States $0.312B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.308B 0.00
ESSA Pharma (EPIX) Canada $0.304B 0.00
Nektar Therapeutics (NKTR) United States $0.288B 0.00
Nanobiotix S.A (NBTX) France $0.288B 0.00
Akebia Therapeutics (AKBA) United States $0.287B 0.00
Eliem Therapeutics (ELYM) United States $0.282B 0.00
Xeris Biopharma Holdings (XERS) United States $0.280B 0.00
Pyxis Oncology (PYXS) United States $0.258B 0.00
Foghorn Therapeutics (FHTX) United States $0.255B 0.00
Adherex Technologies (FENC) United States $0.252B 0.00
Aldeyra Therapeutics (ALDX) United States $0.247B 0.00
Lyra Therapeutics (LYRA) United States $0.246B 0.00
Metagenomi (MGX) United States $0.237B 0.00
Avita Medical (RCEL) United States $0.226B 0.00
Conduit Pharmaceuticals (CDT) United States $0.221B 0.00
Acrivon Therapeutics (ACRV) United States $0.217B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.210B 0.00
Zevra Therapeutics (ZVRA) United States $0.209B 0.00
Galectin Therapeutics (GALT) United States $0.207B 0.00
Century Therapeutics (IPSC) United States $0.196B 0.00
Telomir Pharmaceuticals (TELO) United States $0.184B 0.00
Profound Medical (PROF) Canada $0.180B 0.00
MediWound (MDWD) Israel $0.177B 0.00
Regulus Therapeutics (RGLS) United States $0.173B 0.00
Innate Pharma SA (IPHYF) France $0.171B 0.00
Prelude Therapeutics (PRLD) United States $0.162B 0.00
Achieve Life Sciences (ACHV) Canada $0.162B 0.00
Incannex Healthcare (IXHL) Australia $0.152B 0.00
CytoDyn (CYDY) United States $0.146B 0.00
Elite Pharmaceuticals (ELTP) United States $0.139B 12.98
Amylyx Pharmaceuticals (AMLX) United States $0.138B 2.90
Cardiol Therapeutics (CRDL) Canada $0.136B 0.00
Karyopharm Therapeutics (KPTI) United States $0.132B 0.00
VAXART, INC (VXRT) United States $0.129B 0.00
GlycoMimetics (GLYC) United States $0.118B 0.00
OptiNose (OPTN) United States $0.114B 0.00
FibroGen (FGEN) United States $0.113B 0.00
Citius Pharmaceuticals (CTXR) United States $0.112B 0.00
Relmada Therapeutics (RLMD) United States $0.111B 0.00
Inotiv (NOTV) United States $0.110B 0.00
PMV Pharmaceuticals (PMVP) United States $0.102B 0.00
Assertio Holdings (ASRT) United States $0.098B 7.92
Vivani Medical (VANI) United States $0.098B 0.00
ProPhase Labs (PRPH) United States $0.098B 0.00
Aclaris Therapeutics (ACRS) United States $0.097B 0.00
AlloVir (ALVR) United States $0.092B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.089B 0.00
Jaguar Animal Health (JAGX) United States $0.088B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.086B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.083B 0.00
Tempest Therapeutics (TPST) United States $0.082B 0.00
Journey Medical (DERM) United States $0.074B 0.00
Champions Oncology (CSBR) United States $0.070B 0.00
Carisma Therapeutics (CARM) United States $0.067B 0.00
SCYNEXIS (SCYX) United States $0.067B 0.99
Mural Oncology (MURA) Ireland $0.065B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.058B 0.00
BioLineRx (BLRX) Israel $0.054B 0.00
Gain Therapeutics (GANX) United States $0.053B 0.00
Unicycive Therapeutics (UNCY) United States $0.042B 0.00
Rafael Holdings (RFL) United States $0.040B 0.00
Natural Alternatives (NAII) United States $0.038B 0.00
ElectroCore (ECOR) United States $0.038B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.038B 0.00
CASI Pharmaceuticals (CASI) China $0.037B 0.00
VYNE Therapeutics (VYNE) United States $0.037B 0.00
DURECT (DRRX) United States $0.036B 0.00
JanOne (JAN) United States $0.034B 0.00
Protara Therapeutics (TARA) United States $0.033B 0.00
Surrozen (SRZN) United States $0.032B 0.00
Viracta Therapeutics (VIRX) United States $0.032B 0.00
Enlivex Therapeutics (ENLV) Israel $0.030B 0.00
Nutriband (NTRB) United States $0.027B 0.00
Oncternal Therapeutics (ONCT) United States $0.026B 0.00
Iterum Therapeutics (ITRM) Ireland $0.026B 0.00
Lipocine (LPCN) United States $0.025B 0.00
PolyPid (PYPD) Israel $0.024B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.022B 10.53
NRx Pharmaceuticals (NRXP) United States $0.022B 0.00
TherapeuticsMD (TXMD) United States $0.022B 0.00
Alaunos Therapeutics (TCRT) United States $0.021B 0.00
MEI Pharma (MEIP) United States $0.020B 1.03
CERo Therapeutics Holdings (CERO) United States $0.020B 0.00
Aptorum Group (APM) United Kingdom $0.020B 0.00
BioVie (BIVI) United States $0.020B 0.00
Nuvilex (PMCB) United States $0.018B 0.00
Talphera (TLPH) United States $0.017B 0.00
Indaptus Therapeutics (INDP) United States $0.017B 0.00
Minerva Neurosciences (NERV) United States $0.017B 0.00
Traws Pharma (TRAW) United States $0.016B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.016B 0.00
Mannatech (MTEX) United States $0.015B 0.00
Avalo Therapeutics (AVTX) United States $0.015B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.014B 0.00
Dominari Holdings (DOMH) United States $0.014B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.013B 0.00
Redhill Biopharma (RDHL) Israel $0.013B 0.00
Cosmos Health (COSM) Greece $0.012B 0.00
Molecular Templates (MTEM) United States $0.011B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Biomerica (BMRA) United States $0.009B 0.00
Inhibikase Therapeutics (IKT) United States $0.009B 0.00
Vivos Therapeutics (VVOS) United States $0.008B 0.00
Universe Pharmaceuticals INC (UPC) China $0.008B 0.00
Plus Therapeutics (PSTV) United States $0.008B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.007B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.007B 0.00
Mangoceuticals (MGRX) United States $0.007B 0.00
Ainos (AIMD) United States $0.006B 0.00
Heatwurx (PCSA) United States $0.006B 0.00
XORTX Therapeutics (XRTX) Canada $0.005B 0.00
SHINECO (SISI) China $0.005B 0.00
TransCode Therapeutics (RNAZ) United States $0.005B 0.00
Petros Pharmaceuticals (PTPI) United States $0.005B 0.00
Acutus Medical (AFIB) United States $0.004B 0.00
Phio Pharmaceuticals (PHIO) United States $0.004B 0.00
Finch Therapeutics (FNCH) United States $0.004B 0.00
Clever Leaves Holdings (CLVR) Canada $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
Avenue Therapeutics (ATXI) United States $0.003B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.003B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
Bio-Path Holdings (BPTH) United States $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.001B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Aditxt (ADTX) United States $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.000B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Context Therapeutics (CNTX) United States $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 5.42
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 42.66